Cary Street Partners Investment Advisory’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-255
Closed -$19.6K 947
2023
Q3
$19.6K Buy
255
+5
+2% +$415 ﹤0.01% 1131
2023
Q2
$20.9K Buy
250
+100
+67% +$8.13K ﹤0.01% 1034
2023
Q1
$12.7K Sell
150
-89
-37% -$7.64K ﹤0.01% 1082
2022
Q4
$19.5K Buy
+239
New +$19.3K ﹤0.01% 987
2020
Q4
Sell
-150
Closed -$12K 502
2020
Q3
$12K Buy
+150
New +$11.3K ﹤0.01% 737

Other funds holding EMN

Cary Street Partners Investment Advisory's EMN Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Eastman Chemical (EMN) in Q4 2023, closing a stake of 255 shares — an estimated $19.6K sold.

Cary Street Partners Investment Advisory first reported a position in EMN in Q3 2020 and held it in 5 quarters. The position peaked at $20.9K in Q2 2023. 712 funds tracked by Wall St. Rank hold EMN as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Eastman Chemical position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 255 Eastman Chemical shares in Q4 2023, an estimated $19.6K.
  • Cary Street Partners Investment Advisory first reported a position in Eastman Chemical in Q3 2020 and held it in 5 quarters.
  • Cary Street Partners Investment Advisory's Eastman Chemical position peaked at $20.9K in Q2 2023.
  • 712 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.